Latest News & Features
Americas
Accord Healthcare’s attempt to market a generic version of Pfizer’s Tygacil has hit a brick wall after it was accused of infringing three patents. 16 February 2016
Americas
Law firm Steptoe & Johnson has hired Ying Li as a partner in the firm’s intellectual property group in New York. 16 February 2016
Big Pharma
Eli Lilly has lost the latest round of its patent battle with Allergan centring on the lung cancer drug Alimta. 15 February 2016
Africa
GSK has been fined more than £37 million by the UK government for “anti-competitive conduct” in relation to ‘pay for delay’ deals centring on anti-depressant drug Seroxat. 12 February 2016
Americas
The US Supreme Court should reject a petition arguing that the US Court of Appeals for the Federal Circuit’s should not handle interference proceedings, the Japanese Foundation for Cancer Research has argued. 11 February 2016
Big Pharma
Law firm Fieldfisher has expanded its life sciences patent litigation and intellectual property practice by hiring Diana Sternfeld, Nicole Jadeja, and Rebecca Baines as partners. 11 February 2016
Americas
Mylan has proposed to buy Swedish pharmaceutical company Meda in what would be a $7.2 billion deal. 11 February 2016
Big Pharma
Patient choice is at the heart of plans in the UK to expedite access to pharma-branded medicines in the NHS, but how will innovator companies be affected? LSIPR reports. 11 February 2016
Americas
Following several high-profile decisions by the US Supreme Court making it harder to patent biotech inventions, parties should follow several best practices to give their products the best chance of being patented. Kathryn Hull of Gordon Rees provides some tips. 11 February 2016
Americas
An advisory committee at the US Food and Drug Administration has said that pharmaceutical company Celltrion’s proposed biosimilar used to treat Crohn’s disease and rheumatoid arthritis should be approved for sale. 10 February 2016